This program combines the frequencies of peptides and a new form of frequencies called the Resonant Recognition Model. Virus Detox 1 targets viruses acquired through infection, shedding, and vaccination.
Herpes Simplex 1 & 2
Eczema herpeticum caused by Herpes Simplex
Herpes Virus 3 Varicella-Zoster (Chicken Pox)
Shingles caused by Varicella-Zoster
Herpes Virus 4 Epstein-Barr Virus (Chronic Fatigue)
Herpes Virus 5 Cytomegalovirus
Herpes Virus 6
Herpes Virus 7
Herpes Virus 8
NOTE: Before Virus Detoxing, it is recommended to do the Peptide Detox and the Deep Detox as preparation. Many viruses are called co-infections and are latent in the body, draining energy and affecting the immune system. When these overloads are addressed, the body can begin to operate at an optimum level and return to a positive state of health and homeostasis. It is generally recommended, after Virus detoxing, to address the Bacteria Detox programs. If you have a serious concern regarding bacterial infections, it is recommended to do the Virus Detox 1, followed by the necessary Bacteria Detox program/s then return to complete the Virus Detox programs.
Virus Detox 1
Antiviral (General)
Peptides address general antiviral activity, including membrane disruption, inhibition of viral entry and fusion, immune system balance and support, and antimicrobial effects, offering antiviral properties.
Cytomegalovirus (CMV)
Cytomegalovirus (CMV) is a common herpesvirus causing lifelong latent infection, often asymptomatic in healthy individuals but leading to severe disease in immunocompromised patients, fetuses, or neonates, with manifestations like retinitis, pneumonia, encephalitis, or congenital defects.
Peptides address viral entry inhibition to block attachment/fusion, replication inhibition targeting DNA polymerase or other enzymes, assembly/maturation disruption via terminase or protein interactions, immune enhancement through T-cells, inflammation reduction, host signaling modulation to counteract viral manipulation, antiviral immunity, nuclear egress inhibition, capsid targeting, and tegument protein blockade.
Epstein-Barr Virus (EBV)
Epstein-Barr Virus (EBV) is a common herpesvirus responsible for infectious mononucleosis and linked to lymphomas, carcinomas, and autoimmune disorders through latent infection and oncogenic proteins. An estimated 90% of the global population is infected with EBV.
Peptides address disrupting EBNA1 dimerization and DNA binding to inhibit latent viral genome maintenance and persistence, reducing viral replication, blocking LMP1 oncogenic signaling to prevent B-cell transformation and proliferation, BZLF1 to destroy infected cells and their membranes and elicit immune responses against switching from latency, Glycoprotein targeting to neutralizing EBV glycoproteins like gB to block viral entry and cell-to-cell spread, T-cell epitope stimulation to activate cytotoxic T-cells for eliminating infected cells, and T-cell recognition of early lytic antigens for tumor clearance.
Herpes Simplex Virus 1 (HSV1)
Herpes Simplex Virus 1 (HSV1) is a double-stranded DNA virus in the Herpesviridae family that primarily infects epithelial cells and establishes lifelong latency in sensory neurons, leading to recurrent infections such as oral herpes, keratitis, encephalitis, and, occasionally, systemic disease.
Peptides address latency prevention, antiviral protection, viral genome integration disruption, antimicrobial protection, HSV1 viral entry inhibition and replication, immune system modulation, infection prevention, and viral attachment interference.
Herpes Simplex Virus 2 (HSV2)
Herpes Simplex Virus 2 (HSV2) is a DNA virus that causes genital herpes, characterized by painful sores, recurrent outbreaks due to latency in sensory neurons, and potential complications like neonatal herpes or increased HIV susceptibility. It is estimated that 55% of the global population are carriers of HSV2.
Peptides address viral entry inhibition, direct virucidal activity via membrane disruption and cell attachment prevention, immune response modulation, anti-inflammatory and antimicrobial effects, inhibition of viral replication and latency, and HSV-2 inactivation.
Varicella Zoster Virus (Chicken Pox/Shingles VZV)
Varicella-zoster virus (VZV) is a neurotropic alphaherpesvirus that causes primary varicella (chickenpox), typically in childhood, with symptoms including fever, malaise, and a characteristic pruritic vesicular rash resulting from viral replication in the skin following respiratory entry and viremia. After resolution, VZV establishes latency in sensory ganglia neurons, evading immune clearance through multiple strategies, including interference with interferon signaling, JAK-STAT inhibition, and downregulation of MHC expression. Reactivation later in life, often due to waning cell-mediated immunity with age or immunosuppression, leads to herpes zoster (shingles), manifesting as a painful unilateral dermatomal rash, with potential complications such as postherpetic neuralgia from neuronal inflammation, disseminated infection in immunocompromised patients, or rare encephalitic involvement.
Peptides address innate antiviral defenses, direct viral inhibition, control replication during both primary infection and reactivation when local immune responses are challenged, antimicrobial membrane disruption, and broad-spectrum inhibition of enveloped viruses, including herpesviruses, through entry blockade and virion destabilization.
Shingles
Shingles is a viral infection caused by the reactivation of the varicella-zoster virus, leading to a painful rash, often accompanied by postherpetic neuralgia.
Peptides address antiviral inhibition and replication, anti-inflammatory, reducing rash and swelling, analgesic management for severe neuropathic pain, immunomodulatory, neuroprotection preventing nerve damage, antimicrobial relief reducing virus replication in skin cells, outbreak prevention through immunomodulation, anxiety support, and innate immunity
Resonant Recognition Model (RRM)
RRM frequencies offer a new way to address how proteins and other molecules in living things interact. Think of it like this: proteins are long chains of building blocks, and each chain has a hidden pattern that acts like a specific radio frequency. Just as radios tune into the same station to play the same song, proteins with matching frequencies can “hear” each other and work together, even from a distance.
In this model, the protein’s chain is converted into a series of special numbers, based on how electrons move in each building block. These numbers form a signal, similar to a sound wave. By analyzing that signal, we can identify the main frequency, which is like the dominant note in a chord. Proteins that share the same dominant note are more likely to connect for tasks like fighting infections or sending signals in the body.
Here, the frequency comes from the molecule’s overall makeup, much like how different materials in a bell produce different rings. This helps predict if a substance will interfere with a protein’s frequency, blocking negative effects, such as in viruses. RRM is a tool to design better results by matching or disrupting energy patterns. RRM frequencies address:
Herpes Simplex 1 (50-80% of the world has this virus),
Herpes Simplex 2 (15% of the world has this virus)
Eczema herpeticum caused by Herpes Simplex
Herpes Virus 3 Varicella-Zoster (causes Chicken Pox and shingles)
Shingles caused by Varicella-Zoster
Herpes Virus 4 Epstein-Barr Virus (90% of the world has this virus, causes mononucleosis, lymphoid and epithelial cancers, and Chronic Fatigue Syndrome)
Herpes Virus 5 Cytomegalovirus (80% of the world has this virus, causes severe disease in newborns and the immunocompromised, and is a major cause of post-transplant infections)
Herpes Virus 6 (causes roseola in children, encephalitis, MS, and other serious illnesses)
Herpes Virus 7 (causes roseola in children and febrile illnesses, including seizures),
Herpes Virus 8 (causative agent of Kaposi’s sarcoma and other rare cancers primarily in individuals with advanced HIV/AIDS,
Emotional Balance
Peptides effectively manage stress, anxiety, and emotional responses, thereby promoting overall mental well-being. Emotional disruptions and imbalances can lead to conditions such as anxiety disorders, depression, or chronic stress. Peptides facilitate emotional balance by modulating neurotransmitter release (serotonin, dopamine, GABA), hormonal regulation (Hypothalamic-Pituitary-Adrenal axis via cortisol), neuropeptide signaling for social interaction, anxiety reduction, stress resilience, neuroprotection, anti-inflammatory effects, mood and pain-related emotions, and sleep regulation.
NOTE: Peptide programs were developed over eight years of research to support molecular-level frequency work. Peptide frequencies offer multitudes of benefits for the body. A particular peptide may be in a certain program for its medically researched and acknowledged benefits for a particular challenge; it may also help in many other areas of the body. If your body doesn’t require the benefit of a particular peptide in frequency form, that peptide will not do anything for you and will not have any negative effect.
Testimony from Helene Gross, Certified Hypnotist, NLP
“For 40 years I have dealt with flare-ups from Shingles. I am no longer having any episodes or pain. One of the biggest triggers for flare-ups for me was the sun or stress, and this doesn’t happen anymore! I’ve heard that you can never get rid of these viruses, but I am not living with reactions to the Herpes Varicella any longer because of the Virus Detox 1 program.”